Novel Antiviral Therapies

Antiviral therapy is one of the most exciting aspects of virology, since it has successfully employed basic science to generate very effective treatments for serious viral infections. Most drugs and vaccines, however, selectively target a single virus, thereby providing a “one drug-one bug” solution. In contrast, broad-spectrum antivirals (BSAs) can cover multiple viruses and genotypes and reduce the likelihood of development of resistance. Therefore, some BSAs can be used for the rapid management of new or drug-resistant viral strains, for a first-line treatment. There are two types of anti-viral therapies depending on the type of virus, they are: "episodic" oral antiviral therapy (where antiviral therapy is used intermittently by the patient during a recurrence), or "suppressive" antiviral therapy (where the antiviral therapy is taken continuously to prevent recurrences).

 

    Related Conference of Novel Antiviral Therapies

    June 24-25, 2019

    48th World Congress on Microbiology

    Moscow, Russia
    July 01-02, 2019

    11th International Virology Summit

    Valencia, spain
    July 26-27, 2019

    World Yeast Congress

    Vancouver | Canada
    October 21-22, 2019

    6th World Congress and Expo on Applied Microbiology

    Rome, Italy
    October 23-24, 2019

    2nd Global Experts Meeting on Chronic Diseases

    Tokyo, Japan
    November 06-07, 2019 |

    15th Global Summit on Virology and Microbiology

    Yokohama | Japan
    November 14-15, 2019

    23rd World Congress on Biotechnology

    Amsterdam, Netherlands
    December 04-05, 2019

    Orthodontics and Prosthodontics

    Tokyo, Japan

    Novel Antiviral Therapies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in